Table 2.
Outcomes | SRTT | Control | SRTT vs. Control | ||||||
---|---|---|---|---|---|---|---|---|---|
Mean(SD) | ES | ES 95% CI Low/High | Mean(SD) | ES | ES 95% CI Low/High | Mean(SD) | ES | ES 95% CI Low/High | |
PDQ-39 (%) | 0.05 (9.23) | − 0.01 | − 0.22/0.21 | 6.65 (14.52) | 0.50 | 0.17/0.82 | 7.70 (14.93) | − 0.71 | − 1.12/− 0.31 |
Walking (%) | 0.04 (0.73) | − 0.05 | − 0.33/0.24 | 0.38 (0.73) | 0.47 | 0.16/0.77 | 0.55 (0.95) | − 0.47 | − 0.90/− 0.04 |
Posture (%) | 0.23 (0.60) | 0.23 | 0.05/0.41 | 0.28 (0.84) | 0.41 | 0.01/0.80 | 0.03 (0.82) | 0.08 | − 0.28/0.44 |
NFOGQ (%) | 2.05 (3.63) | 0.29 | 0.14/0.44 | 1.89 (4.83) | 0.25 | 0.06/0.44 | 0.28 (3.23) | 0.04 | − 0.33/0.42 |
SRTT Supervised, real-time videoconferencing telerehabilitation, Control Nonexercising control group, PDQ-39 Parkinson’s Disease Questionnaire, NFOGQ New-freezing of gait questionnaire